Alterity Therapeutics Limited

(ATHE) Trade

By |

Profile

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.

Contact Information

Website: www.alteritytherapeutics.com
Email: info@pranabio.com
Main Phone: +61 393494906
Address: 460 Bourke Street
Address 2: Level 3
State: VIC
City / Town: Melbourne
Country: AUS
Postal Code: 3000

Issuer Information

Exchange: NSC
CEO: Geoffrey Paul Kempler
Employees: 14

Equities News

Profile

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaboration with Takeda for the treatment of Parkinson's disease gastrointestinal neuropathology. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (PBT434) and brain cancer (PBT519), which are in pre-clinical toxicology testing.

Contact Information

Website: www.alteritytherapeutics.com
Email: info@pranabio.com
Main Phone: +61 393494906
Address: 460 Bourke Street
Address 2: Level 3
State: VIC
City / Town: Melbourne
Country: AUS
Postal Code: 3000

Issuer Information

Exchange: NSC
CEO: Geoffrey Paul Kempler
Employees: 14

Equities News

$ 0.73 $ -0.0401 (-5.21%)
Last Price 0.73 Change $ -0.0401 Change % -5.21 Tick N/A
Bid N/A Bid Size 0.00 Ask N/A Ask Size 0.00
Open 0.77 High 0.79 Low 0.72 Prev Close 0.77
Last Trade Volume 18,642 52 Wk Hi 2.73 52 Wk Low 0.67
Market Cap 10.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 14,543,564.00 EPS (TTM) -0.79 PE Ratio N/A Exchange NCM
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 4 4 4 4
Low Target Price Estimate 4 4 4 4
Mean Target Price Estimate 4 4 4 4
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 03/22/18 03/22/18 03/22/18 03/22/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 1
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 0 0 0 1